This website uses cookies and is meant for marketing purposes only.
The Board of Directors of IPEC Holdings (iFOREX Trading) plays a central role in overseeing the company’s strategic direction, governance standards, and long-term performance. Through a framework of effective leadership and prudent oversight, the Board ensures that the company operates responsibly, manages risk effectively, and upholds the interests of its shareholders, clients, and wider stakeholders.
Itai Sadeh,
CEO
Mr Itai Sadeh is the Chief Executive Officer of the Group and was appointed as Executive Director in 2025.
Since June 2023, Itai Sadeh has been the Chief Executive Officer of I For Fintech Ltd., an Israeli incorporated subsidiary of the Company, having previously from July 2020 been a Senior Advisor to the board of the Company. Itai is an experienced executive with extensive experience in corporate development, regulatory and legal affairs and financial technology and has been providing services to the Group since May 2011.
Before joining the Group, Itai held the position of General Counsel at RRsat Global Communications Network Ltd., then a public company listed on NASDAQ (it was later acquired by SES S.A.).
Itai is a qualified lawyer and a member of the Israeli Bar Association holding an LL.B. in Law from The Hebrew University of Jerusalem and an LL.M. in Commercial Law (with honours) from the executive program of the Tel Aviv University in collaboration with the University of California, Berkeley.
Shirley Winkler Hollander,
CFO
Mrs Shirley Winkler Hollander is the Chief Financial Officer of the Group and was appointed as Executive Director in 2025.
Shirley Winkler Hollander joined as the Chief Financial Officer of the Group in October 2024. Shirley has over a decade of experience in finance and accounting and has expertise in financial regulation and policies.
Before joining the Group, Shirley served as the Director of Finance at STK Bio-Ag Technologies from June 2021 to July 2024. Prior to that, she was the Associate Director of Accounting at Teva Pharmaceuticals from October 2017 to June 2021.
Shirley was also an Assurance Manager at Ernst & Young specialising in auditing and financial analysis from December 2010 to September 2017. Her diverse experience has equipped her with a comprehensive understanding of the financial landscape.
Shirley holds a Bachelor’s degree in Economics from Ben-Gurion University of the Negev.
${mi_info_text}